Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kenneth Alan Freedberg, M.D.

Co-Author

This page shows the publications co-authored by Kenneth Freedberg and Emily Hyle.
Connection Strength

3.522
  1. HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care? J Acquir Immune Defic Syndr. 2014 Sep 01; 67 Suppl 1:S87-95.
    View in: PubMed
    Score: 0.589
  2. College Campuses and COVID-19 Mitigation: Clinical and Economic Value. Ann Intern Med. 2021 04; 174(4):472-483.
    View in: PubMed
    Score: 0.228
  3. Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adults Experiencing Sheltered Homelessness During the COVID-19 Pandemic. JAMA Netw Open. 2020 12 01; 3(12):e2028195.
    View in: PubMed
    Score: 0.227
  4. Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic. medRxiv. 2020 Oct 20.
    View in: PubMed
    Score: 0.225
  5. College campuses and COVID-19 mitigation: clinical and economic value. medRxiv. 2020 Sep 05.
    View in: PubMed
    Score: 0.223
  6. Clinical Impact and Cost-effectiveness of Genotype Testing at Human Immunodeficiency Virus Diagnosis in the United States. Clin Infect Dis. 2020 03 17; 70(7):1353-1363.
    View in: PubMed
    Score: 0.216
  7. Cost-effectiveness of a Medical Care Coordination Program for People With HIV in Los Angeles County. Open Forum Infect Dis. 2019 Dec; 6(12):ofz537.
    View in: PubMed
    Score: 0.212
  8. Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2017 10 15; 65(8):1266-1271.
    View in: PubMed
    Score: 0.183
  9. The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations. AIDS. 2017 09 24; 31(15):2135-2145.
    View in: PubMed
    Score: 0.182
  10. The value of point-of-Care CD4 and Laboratory viral Load in tailoring ART monitoring Strategies to resource limitations. AIDS. 2017 Jul 07.
    View in: PubMed
    Score: 0.179
  11. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis. PLoS Med. 2014 Sep; 11(9):e1001725.
    View in: PubMed
    Score: 0.148
  12. Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness. PLoS One. 2014; 9(1):e85197.
    View in: PubMed
    Score: 0.141
  13. Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis. Ann Intern Med. 2022 Feb 01.
    View in: PubMed
    Score: 0.062
  14. Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts. Clin Infect Dis. 2021 11 02; 73(9):e2908-e2917.
    View in: PubMed
    Score: 0.060
  15. Modeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic Projections. AIDS Behav. 2021 Sep; 25(9):2973-2984.
    View in: PubMed
    Score: 0.057
  16. Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. Lancet Glob Health. 2021 02; 9(2):e120-e129.
    View in: PubMed
    Score: 0.057
  17. Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. medRxiv. 2020 Oct 11.
    View in: PubMed
    Score: 0.056
  18. Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts. medRxiv. 2020 Jul 24.
    View in: PubMed
    Score: 0.055
  19. Waiting for Certainty on Covid-19 Antibody Tests - At What Cost? N Engl J Med. 2020 Aug 06; 383(6):e37.
    View in: PubMed
    Score: 0.055
  20. Novel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US population. BMJ Open. 2020 05 12; 10(5):e032579.
    View in: PubMed
    Score: 0.055
  21. Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa. PLoS One. 2019; 14(11):e0225104.
    View in: PubMed
    Score: 0.053
  22. Using Observational Data to Calibrate Simulation Models. Med Decis Making. 2018 02; 38(2):212-224.
    View in: PubMed
    Score: 0.046
  23. Lung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United States. JAMA Intern Med. 2017 11 01; 177(11):1613-1621.
    View in: PubMed
    Score: 0.046
  24. The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States. J Infect Dis. 2017 10 17; 216(7):798-807.
    View in: PubMed
    Score: 0.046
  25. Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid. Ann Intern Med. 2017 Nov 07; 167(9):618-629.
    View in: PubMed
    Score: 0.045
  26. The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa. Ann Intern Med. 2016 09 06; 165(5):325-33.
    View in: PubMed
    Score: 0.042
  27. Diagnostic point-of-care tests in resource-limited settings. Lancet Infect Dis. 2014 Mar; 14(3):239-49.
    View in: PubMed
    Score: 0.035
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.